Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Harkonen
Case Number:
3:08-cr-00164
Court:
Nature of Suit:
Judge:
Firms
-
May 15, 2017
Ex-InterMune CEO Says Expert Would Have Changed Verdict
The former CEO of InterMune asked a Ninth Circuit panel Monday to revive his request that a California federal judge reverse his 2009 wire fraud conviction, claiming his attorneys never presented biostatistical expert testimony that could have cleared him of allegations he made false statements about the effectiveness of a lung disease drug.
-
August 24, 2015
Ex-InterMune CEO's Complaints Against Trial Counsel Nixed
A California federal judge on Friday shot down claims by the former CEO of biotech company InterMune Inc. that he deserved to have his verdict set aside after being convicted of wire fraud in 2009 because his attorneys decided not to call any defense experts during trial, finding the argument was made too late and that the attorneys' decision was reasonable.
-
April 19, 2011
No New Trial For Former InterMune CEO
The former CEO of InterMune Inc., convicted of fraudulently marketing the drug Actimmune to treat a deadly lung disease, was denied a new trial Monday after a California federal judge ruled that previously undisclosed documents didn't prejudice the case against him.
-
April 14, 2011
Ex-InterMune CEO Gets House Arrest For Drug Claims
The former CEO of InterMune Inc., convicted of fraudulently marketing his company's drug Actimmune for a deadly lung disease, was sentenced in San Francisco on Wednesday to six months of home confinement and three years' probation.